- Home
- Media Center
- Press releases
- Innovative Medicine
Innovative Medicine
Zytiga® Approved In The European Union For Metastatic Castration-Resistant Prostate Cancer
First once-daily, oral treatment inhibits androgen production at all sources
Young Patients To Benefit From Health Canada Approval Of Remicade®* For Treatment Of Pediatric Ulcerative Colitis
Canadian Children Six To 17 Years Old Become The First Worldwide To Benefit From A New Biologic Treatment Option Approved For Chronic Inflammatory Bowel Disease
NUCYNTA® ER (Tapentadol Extended-Release Tablets) Receives FDA Approval For The Management Of Moderate To Severe Chronic Pain
Clinical Trial Data Demonstrate Efficacy, Safety and Favorable Tolerability
Celebrity Chef Sam Talbot Joins “Life First™” Diabetes Awareness Campaign
Talbot Partners With OneTouch® Brand Blood Glucose Monitoring Systems To Help People Learn To Manage Diabetes While Living Life Without Limits
Zytiga™* (Abiraterone Acetate) Receives Health Canada Approval For Treatment Of Metastatic Prostate Cancer
First Oral Treatment for Metastatic Prostate Cancer That Inhibits Androgen Production at All Three Sources
Survey Finds More Than 1 In 3 Americans Have Been Personally Affected By Infections Resulting From A Hospital Stay
Innovative Technology Now Available to Disinfect Healthcare Environment, Helping Protect Patients from Environmental Pathogens